HIV-1 resistance mutations and plasma RNA during zidovudine plus zalcitabine combination therapy

被引:0
|
作者
Sylvester, A
Caliendo, A
An, D
Savara, A
Byington, R
Strick, D
Lillaney, R
Sutton, L
Sepkowitz, K
Fischl, M
Simon, G
Lalezari, J
Mitsuyasu, R
DAquila, R
机构
[1] NEW YORK HOSP,NEW YORK,NY 10021
[2] UNIV MIAMI,MIAMI,FL 33152
[3] WASHINGTON UNIV,ST LOUIS,MO
[4] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[5] UNIV CALIF LOS ANGELES,LOS ANGELES,CA
[6] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
[7] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:47 / 47
页数:1
相关论文
共 50 条
  • [21] Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy
    Ait-Khaled, M
    Rakik, A
    Griffin, P
    Cutrell, A
    Fischl, AA
    Clumeck, N
    Greenberg, SB
    Rubio, R
    Peters, BS
    Pulido, F
    Gould, J
    Pearce, G
    Spreen, W
    Tisdale, A
    Lafon, S
    ANTIVIRAL THERAPY, 2002, 7 (01) : 43 - 51
  • [22] HIV-1 RNA SERUM-LOAD AND RESISTANT VIRAL GENOTYPES DURING EARLY ZIDOVUDINE THERAPY
    LOVEDAY, C
    KAYE, S
    TENANTFLOWERS, M
    SEMPLE, M
    AYLIFFE, U
    WELLER, IVD
    TEDDER, RS
    LANCET, 1995, 345 (8953): : 820 - 824
  • [23] Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: Effect of switching to didanosine or zidovudine plus didanosine therapy
    Principi, N
    Marchisio, P
    Esposito, S
    Rossi, P
    Gattinara, GC
    Galli, L
    Gabiano, C
    Zuccotti, GV
    Orlandi, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (18) : 1653 - 1659
  • [24] HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
    Gisslén, M
    Norkrans, G
    Svennerholm, B
    Hagberg, L
    AIDS, 1998, 12 (01) : 114 - 116
  • [25] Correlation of plasma HIV-1 RNA level and development of resistance mutations to AZT and ddI with disease progression in patients with advanced HIV-1 disease and little or no AZT therapy
    Crumpacker, C
    Welles, S
    YenLieberman, B
    Demeter, L
    Japour, A
    Smeaton, L
    Johnson, V
    Kuritzes, D
    DAquila, R
    Reichelderfer, P
    Richman, D
    Reichman, R
    McLaren, C
    Todd, J
    Kwok, S
    Coombs, R
    Jackson, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 42 - 42
  • [26] Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1
    Mathiesen, Sofie
    Dam, Elisabeth
    Roge, Birgit
    Joergensen, Louise Brunn
    Laursen, Alex Lund
    Gerstoft, Jan
    Clavel, Francois
    ANTIVIRAL THERAPY, 2007, 12 (03) : 335 - 343
  • [27] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING THERAPY
    LARDER, BA
    OSULLIVAN, E
    KEMP, SD
    RAMAUTARSING, C
    LANGE, JMA
    GOUDSMIT, J
    BOUCHER, CAB
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 342 - 343
  • [28] Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy
    Welles, SL
    Jackson, JB
    YenLieberman, B
    Demeter, L
    Japour, AJ
    Smeaton, LM
    Johnson, VA
    Kuritzkes, DR
    DAquila, RT
    Reichelderfer, PA
    Richman, DD
    Reichman, R
    Fischl, M
    Dolin, R
    Coombs, RW
    Kahn, JO
    McLaren, C
    Todd, J
    Kwok, S
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 696 - 703
  • [29] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
    Gianella, Sara
    von Wyl, Viktor
    Fischer, Marek
    Niederoest, Barbara
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
  • [30] ZIDOVUDINE THERAPY OF HIV-1 INFECTION DURING PREGNANCY - ASSESSMENT OF THE EFFECT ON THE NEWBORNS
    FERRAZIN, A
    DEMARIA, A
    GOTTA, C
    MAZZARELLO, G
    CANESSA, A
    CIRAVEGNA, B
    CIRILLO, C
    MELICA, F
    TERRAGNA, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (04): : 376 - 379